MediciNova, Inc. (TYO:4875)

Japan flag Japan · Delayed Price · Currency is JPY
261.00
-1.00 (-0.38%)
Feb 16, 2026, 3:24 PM JST
Market Cap11.12B -28.3%
Revenue (ttm)38.17M
Net Income-1.78B
EPS-36.24
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume52,800
Average Volume103,255
Open257.00
Previous Close262.00
Day's Range257.00 - 265.00
52-Week Range164.00 - 314.00
Betan/a
RSI50.24
Earnings DateFeb 13, 2026

About MediciNova

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2b/3 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence a... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 13
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4875
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements